Abiopharma

Net Asset Value(s)

L1 Capital Pty Ltd 🔴 sold 7.3M shares (2 derivative) of Anteris Technologies Global Corp. (AVR) at $11.50 ($21.1M) Transaction Date: Aug 10, 2026 | Filing ID: 000020

Financial Statements and Related Announcement: Half Yearly Results

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-08-12 <b>AccNo:</b> 0001918704-26-023503 <b>Size:</b> 856 KB

New Form 424B5 - CleanCore Solutions, Inc. <b>Filed:</b> 2026-08-12 <b>AccNo:</b> 0001213900-26-088085 <b>Size:</b> 462 KB

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Directors Interest

New Form SCHEDULE 13G/A - CHECK POINT SOFTWARE TECHNOLOGIES LTD <b>Filed:</b> 2026-08-12 <b>AccNo:</b> 0001178913-26-004055 <b>Size:</b> 6 KB

New Form 424B5 - UNITED PARCEL SERVICE INC <b>Filed:</b> 2026-08-12 <b>AccNo:</b> 0001104659-26-094564 <b>Size:</b> 468 KB

Warrants Listing - Structured Warrants: Proposed Issue of Put Warrants

General Announcement: Section 1446(a) Qualified Notice with respect to 1H2026 Distribution Payment in September 2026

Cash Dividend/ Distribution with Choice:

Financial Statements and Related Announcement: Half Yearly Results

Warrants Listing - Structured Warrants: Proposed Issue of Call Warrants

Financial Statements and Related Announcement: Half Yearly Results

(30% Negative) AMCOR PLC (AMCR) Reports Q3 2026 Financial Results